Primary resistance to clarithromycin in helicobacter pylori isolates;Resistencia primaria a la claritromicina en aislamientos de helicobacter pylori

Revista Colombiana de Gastroenterologia

Volumn 24, Issue 2, 2009, Pages 110-114

  Henao Riveros, Sandra Consuelo ^a   Quiroga, Andrés ^b   Martínez Marín, Julián David ^a   Otero Regino, William ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b Instituto Nacional de Cancerología   (Colombia)

Author keywords

Clarithromycin; Helicobacter pylori; Resistance

Indexed keywords

EID: 73149086159     PISSN: 01209957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Makola D, Peura DA, Crowe SE. Helicobacter pylori infection and related gastrointestinal diseases. J Clin Gastroenterol 2007; 41: 548-558.
2. Go MF. Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16(Suppl 1): 3-15.
3. International Agency for Reseach on Cancer, IARC monographs on the evaluation of carcinogenic risk to humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon IARC 1994; 61: 177-200.
4. Cover TL, Blazer MJ. Helicobacter pylori, a paradigm for chronic mucosa inflammation: Pathogenesis and implication for eradication and prevention. Adv Int Med 1996; 41: 85-117.
5. Bedoya A, Arcos M, Sansón F, del Castillo G. Helicobacter pylori y cambios histológicos de la mucosa gástrica en menores de diez años. Pasto, 1999. Rev Colomb Gastroenterol 2002; 17: 36-42.
6. Martínez JD, Henao SC, Granados C. La gastritis crónica atrófica y la edad. Rev Colomb Gastroenterol 2007; 22: 17-22.
7. Grove DI, Koutsouridis G, Cummins AG. Comparison of culture, histopathology and urease testing for diagnosis of Helicobacter pylori gastritis and susceptibility to amoxicillin, clarithromycin, metronidazole and tetracycline. Pathology 1998; 30: 183-187.
8. Ozcay F, Kocak N, Temizel IN, Demir OH, Ozen H, Yuce A et al. Helicobacter pylori infection in Turkish children: comparison of diagnosis test, evaluation of eradication rate, and change symptoms after erradicatio. Helicobacter 2004; 9: 242-248.
9. Van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WGV, de Boer AW.Importance of Helicobacter pylori vacA and cagA status for the efficacy antibiotic treatment. Gut 2000; 46; 321-326.
10. Mégraud F. H pylori Antibiotic resistance: prevalence, importance, and advances in testing. Gut 2004; 53: 1374-1384.
11. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Reviews. 2007; 20(2): 280-322.
12. Fariña N, Kasamatsu E, Samudio M, Morán M, Sanabria R, Laspina F. Susceptibilidad a antibióticos de cepas paraguayas de Helicobacter pylori aisladas de pacientes con enfermedad gastroduodenal. Rev Med Chile 2007; 135:1009-1014.
13. Díaz-Regañón J, Alarcón T, Domingo F, López Brea M. Sensibilidad de 36 aislamientos de Helicobacter pylori a cuatro antibióticos de primera línea y características de virulencia. Rev Esp Quimioterap 2008; 19: 34-38.
14. Osato MS. Antimicrobial Susceptibility Testing for Helicobacter pylori: Sensitivity Test Results and Their Clinical Relevance. Current Pharmaceutical Design 2000; 6: 1545-1555.
15. Fuccio L, Laterza L, Zagari RM, Cennamo V, Grilli D, Bazzoli F. Treatment of Helicobacter pylori infection. BMJ 2008; 337: 746-750.
16. Bytzer P, O'Morain C. Treatment of Helicobacter pylory. Helicobacter 2005; 10(Suppl. I): 40-46.
17. Grove DI, Koutsouridis G. Increasing resistance of Helicobacter pylori to Clarithromycin: is the horse bolting? Pathology 2002; 34: 71-73.
18. Pajares García JM, Pajares-Villarroya R, Gisbert JP. Helicobacter pylori infection: antibiotic resistance. Rev Esp Enferm Dig 2007; 99: 63-70.
19. Duck WM, Sobel J, Bruckner JM. Antimicrobial resistance, incidence and risk factors among Helicobacter pylori infected persons, in the United States. Emerg Infect Dis 2004; 10: 1088-94.
20. Kobayashi I, Murakami K, Kato M, Kato S, Azuma T, Takahashi S, et al. Changing Antimicrobial Susceptibility Epidemiology of Helicobacter pylori Strains in Japan between 2002 and 2005. J of Clin Microbiol 2007; 45: 4006-4010.
21. Yepes CA, Rodríguez A, Ruiz A, Ariza B. Resistencia antibiótica del Helicobacter pylori en el Hospital Universitario San Ignacio de Bogotá. Acta Médica Colombiana 2008; 33: 11-14.
22. Vallejos C, Garrido L, Dante-Cáceres L, Madrid AM, De Filippi C, Toledo H. Prevalencia de la resistencia a metronidazol, claritromicina y tetraciclina en Helicobacter pylori aislado a pacientes de la región metropolitana. Rev Med Chile 2007; 135: 287-293.
23. Mendoca S, Ecclissato C, Sartori MS, Ortiz AP, Degger M, Pedrazzoli J, et al. Prevalence of Helicobacter pylory resistance to metronidazole, Clarithromicin, Amoxicillin, tetracycline and furazolidone in Brazil. Helicobacter 2000; 5: 79-83.
24. Lee MG, Arthurs M, Smikle MF, Dowe G, Leny V, Barton EN. Antibiotic sensibility of Helicobacter pylori in Jamaica. West Indian Med J 2004; 53: 374-377.
25. Torres J, Carmorlinga-Ponce M, Pérez-Pérez G, Madrazo A, Dehesa M, González G, et al. Increasing multidrug resistance in Helicobacter pylori strains isolated from children and adults in Mexico. J of Clin Microbiol 2001; 39: 2677-2680.
26. Urrestarazu M, Serrano N, Piñero R, Cavazza M. Susceptibilidad del Helicobacter pylori a los antimicrobianos. Rev Soc Venez Microbiol 2003; 23: 14-15.
27. Riva F, Rivera P, Hernández F, Hevia F, Guillen F, Ricamayo G. Antibioticosensibilidad del Helicobacter pylori mediante microdilución. Rev Med Panamá 2000; 25: 19-23.
28. Douglin E, Charles G, Levett P. Antimicrobial resistente of Helicobacter pylori in Barbados. West Indian Med J 2000; 49(Suppl 2): 36.
29. González C, García A, Daroch F, Kawaguchi F, Solar H, Rivera N, et al. Susceptibilidad in vitro de cepas de Helicobacter pylori: aislamiento de cepas resistentes a claritromicina. Rev Med Chile 2001; 129: 643-646.
30. Anayanssi A, Rivera P, Hevia F, Guillen F, Hernández F. Helicobacter pylori, la necesidad de estandarizar las pruebas de susceptibilidad a los antibióticos. GEN 2001, 55: 17-21.